Atif J. Khan

6.4k total citations
195 papers, 3.5k citations indexed

About

Atif J. Khan is a scholar working on Cancer Research, Radiation and Oncology. According to data from OpenAlex, Atif J. Khan has authored 195 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Cancer Research, 64 papers in Radiation and 61 papers in Oncology. Recurrent topics in Atif J. Khan's work include Breast Cancer Treatment Studies (121 papers), Advanced Radiotherapy Techniques (64 papers) and Breast Lesions and Carcinomas (43 papers). Atif J. Khan is often cited by papers focused on Breast Cancer Treatment Studies (121 papers), Advanced Radiotherapy Techniques (64 papers) and Breast Lesions and Carcinomas (43 papers). Atif J. Khan collaborates with scholars based in United States, United Kingdom and Canada. Atif J. Khan's co-authors include Bruce G. Haffty, Frank A. Vicini, Sharad Goyal, Chirag Shah, Douglas W. Arthur, Darryl Carter, David E. Wazer, Michael P. DiGiovanna, Shabbar F. Danish and Martin Keisch and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Atif J. Khan

170 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atif J. Khan United States 30 1.6k 1.2k 975 865 812 195 3.5k
Icro Meattini Italy 29 1.6k 1.0× 1.4k 1.2× 983 1.0× 1.6k 1.9× 868 1.1× 238 4.0k
Francisco Perera Canada 26 2.1k 1.3× 1.2k 1.0× 951 1.0× 570 0.7× 759 0.9× 53 3.2k
Patricia H. Hardenbergh United States 24 2.2k 1.4× 914 0.8× 965 1.0× 650 0.8× 760 0.9× 52 3.7k
Kyung Hwan Shin South Korea 33 1.5k 0.9× 1.0k 0.9× 725 0.7× 831 1.0× 930 1.1× 161 3.3k
Eleanor Harris United States 32 2.3k 1.4× 1.2k 1.0× 1.0k 1.0× 836 1.0× 645 0.8× 123 3.9k
Rainer Souchon Germany 27 1.6k 1.0× 1.1k 0.9× 535 0.5× 1.1k 1.3× 1.1k 1.3× 98 3.4k
C. Bourgier France 31 1.2k 0.7× 1.2k 1.1× 517 0.5× 1.1k 1.2× 375 0.5× 163 3.1k
Charlotte E. Coles United Kingdom 32 1.6k 1.0× 688 0.6× 1.1k 1.1× 747 0.9× 539 0.7× 92 3.0k
J.J. Jager Netherlands 23 2.5k 1.6× 1.1k 0.9× 962 1.0× 716 0.8× 994 1.2× 51 3.8k
Birgitte Vrou Offersen Denmark 32 2.3k 1.4× 986 0.8× 1.0k 1.0× 684 0.8× 698 0.9× 125 3.3k

Countries citing papers authored by Atif J. Khan

Since Specialization
Citations

This map shows the geographic impact of Atif J. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atif J. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atif J. Khan more than expected).

Fields of papers citing papers by Atif J. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atif J. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atif J. Khan. The network helps show where Atif J. Khan may publish in the future.

Co-authorship network of co-authors of Atif J. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Atif J. Khan. A scholar is included among the top collaborators of Atif J. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atif J. Khan. Atif J. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braunstein, Lior Z., Melissa P. Mitchell, Hanna Bandos, et al.. (2025). NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer. Future Oncology. 21(16). 2017–2025.
2.
Terry, Alexander R., Boris Mueller, J. Isabelle Choi, et al.. (2025). Partial Breast Irradiation for High Molecular Risk Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 123(5). 1241–1246.
3.
Mueller, Boris, Yulin Song, Simon N. Powell, et al.. (2025). Tattoo-less chest wall and regional nodal irradiation using surface imaging. Technical Innovations & Patient Support in Radiation Oncology. 34. 100310–100310.
4.
McMillan, Matthew T., Atif J. Khan, Simon N. Powell, et al.. (2024). Spatially Fractionated Radiotherapy in the Era of Immunotherapy. Seminars in Radiation Oncology. 34(3). 276–283. 8 indexed citations
5.
Ma, Jennifer, Rachna Shah, Andrew Bell, et al.. (2024). Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors. International Journal of Radiation Oncology*Biology*Physics. 121(3). 768–779.
6.
Braunstein, Lior Z., Boris Mueller, John Cuaron, et al.. (2024). Accelerated Partial Breast Irradiation for Early-Stage Invasive Lobular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 121(4). 894–899. 1 indexed citations
7.
Ferraro, Emanuela, Atif J. Khan, George Plitas, et al.. (2024). Abstract PO3-04-07: Characterization of response to first-line chemotherapy, trastuzumab, and pertuzumab among patients with de novo metastatic HER2-positive breast cancer. Cancer Research. 84(9_Supplement). PO3–4. 1 indexed citations
8.
Khan, Atif J., et al.. (2024). P3.03I.16 Treatment Outcomes in Patients who Received Bevacizumab Therapy for Radiation Induced Brain Necrosis. Journal of Thoracic Oncology. 19(10). S316–S316.
9.
Flynn, Jessica, Zhigang Zhang, Erin F. Gillespie, et al.. (2023). Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ. Advances in Radiation Oncology. 8(5). 101254–101254. 1 indexed citations
10.
Narayan, Priyanka, Zhigang Zhang, Boris Mueller, et al.. (2023). Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival. Breast Cancer Research and Treatment. 199(2). 355–361. 5 indexed citations
11.
Mueller, Boris, Yulin Song, Simon N. Powell, et al.. (2023). Accuracy and Efficiency of Patient Setup Using Surface Imaging versus Skin Tattoos for Accelerated Partial Breast Irradiation. Advances in Radiation Oncology. 8(3). 101183–101183. 5 indexed citations
12.
Ward, Matthew C., Abram Recht, Frank A. Vicini, et al.. (2022). Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and Older. International Journal of Radiation Oncology*Biology*Physics. 116(3). 617–626. 8 indexed citations
13.
Tadros, Audree B., Emily C. Zabor, Erin F. Gillespie, et al.. (2020). Feasibility of Breast-Conservation Therapy and Hypofractionated Radiation in the Setting of Prior Breast Augmentation. Practical Radiation Oncology. 10(5). e357–e362. 3 indexed citations
14.
Tadros, Audree B., Tracy‐Ann Moo, Michelle Stempel, et al.. (2020). Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy. Breast Cancer Research and Treatment. 180(1). 197–205. 11 indexed citations
15.
Belkacémi, Yazid, Pauline T. Truong, Atif J. Khan, et al.. (2017). Adjuvant nodal radiotherapy in the era of sentinel node biopsy staging of breast cancer: A review of published guidelines and prospective trials and their implications on clinical practice. Critical Reviews in Oncology/Hematology. 112. 171–178. 4 indexed citations
16.
Shaitelman, Simona F., Beatriz E. Amendola, Atif J. Khan, et al.. (2016). American Brachytherapy Society Task Group Report: Long-term control and toxicity with brachytherapy for localized breast cancer. Brachytherapy. 16(1). 13–21. 8 indexed citations
17.
Mehta, Monal, Atif J. Khan, Shabbar F. Danish, Bruce G. Haffty, & Hatem E. Sabaawy. (2015). Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition. Molecular Cancer Therapeutics. 14(5). 1171–1180. 35 indexed citations
18.
Khan, Atif J., Sarah A. Milgrom, Nicola Barnard, et al.. (2014). Basal Subtype, as Approximated by Triple-Negative Phenotype, is Associated with Locoregional Recurrence in a Case–Control Study of Women with 0–3 Positive Lymph Nodes After Mastectomy. Annals of Surgical Oncology. 21(6). 1963–1968. 4 indexed citations
19.
Shah, Chirag, Shahed N. Badiyan, Sameer Berry, et al.. (2014). Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy. Radiotherapy and Oncology. 112(1). 9–16. 120 indexed citations
20.
Khan, Atif J., B. Wall, Devora Schiff, et al.. (2011). Riluzole Enhances Ionizing Radiation–Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo. Clinical Cancer Research. 17(7). 1807–1814. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026